Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity
The design of highly defective herpes simplex virus (HSV) vectors for transgene expression in nonneuronal cells in the absence of toxic viral-gene activity has been elusive. Here, we report that elements of the latency locus protect a nonviral promoter against silencing in primary human cells in the...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 112; no. 13; pp. E1632 - E1641 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
31.03.2015
National Acad Sciences |
Series | PNAS Plus |
Subjects | |
Online Access | Get full text |
ISSN | 0027-8424 1091-6490 1091-6490 |
DOI | 10.1073/pnas.1423556112 |
Cover
Summary: | The design of highly defective herpes simplex virus (HSV) vectors for transgene expression in nonneuronal cells in the absence of toxic viral-gene activity has been elusive. Here, we report that elements of the latency locus protect a nonviral promoter against silencing in primary human cells in the absence of any viral-gene expression. We identified a CTCF motif cluster 5′ to the latency promoter and a known long-term regulatory region as important elements for vigorous transgene expression from a vector that is functionally deleted for all five immediate-early genes and the 15-kb internal repeat region. We inserted a 16.5-kb expression cassette for full-length mouse dystrophin and report robust and durable expression in dystrophin-deficient muscle cells in vitro. Given the broad cell tropism of HSV, our design provides a nontoxic vector that can accommodate large transgene constructs for transduction of a wide variety of cells without vector integration, thereby filling an important void in the current arsenal of genetherapy vectors. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Author contributions: Y.M., J.B.C., and J.C.G. designed research; Y.M., P.M., G.V., H.U., W.F.G., S.Y., O.Y., and J.M. performed research; D.A.G. contributed new reagents/analytic tools; Y.M., J.B.C., and J.C.G. analyzed data; and Y.M., J.B.C., and J.C.G. wrote the paper. Edited by Kenneth I. Berns, University of Florida College of Medicine, Gainesville, FL, and approved February 24, 2015 (received for review December 10, 2014) 1Present address: Division of Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1423556112 |